- Research works
- 28 ▲ 83% vs 2013–17
- Citations
- 713 25.8 per fractional work
- Top-10% rate
- 9.2% record average 16.5%
- Open access
- 50% world 28%
Not ranked overall: Immuneering (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 10.2×. Every wedge is a field page.
Which keywords describe research at Immuneering (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Machine Learning, Immunotherapy, Cancer Therapy, Chemotherapy, Targeted Therapy, Pharmacokinetics, Medicinal Chemistry and Cancer Genomics.
- Neoadjuvant Therapy
- Tumor Microenvironment
- Gene Expression
- Cell Proliferation
- Cancer
- Signal Transduction
- Molecular Docking
- Cancer Genomics
- Pharmacokinetics
- Chemotherapy
- Immunotherapy
- Machine Learning
- Cancer Therapy
- Medicinal Chemistry
- Targeted Therapy
- Mutational Signatures
- Oxidative Stress
- Virtual Screening
- Immune Response
- BRAF gene
- MAP Kinase
- Tumor Targeting
- Precision Medicine
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 23 words, with their numbers
- Machine Learning3▲ 5.5×7 topics
- Immunotherapy3▲ 15×7 topics
- Cancer Therapy2▲ 11×5 topics
- Chemotherapy2▲ 9.0×5 topics
- Medicinal Chemistry2▲ 16×2 topics
- Pharmacokinetics2▲ 22×2 topics
- Targeted Therapy2▲ 29×2 topics
- Cancer Genomics2▲ 104×1 topic
- Mutational Signatures2▲ 104×1 topic
- Molecular Docking2▲ 38×1 topic
- Oxidative Stress2▲ 2.9×8 topics
- Signal Transduction2▲ 22×4 topics
- Virtual Screening2▲ 77×1 topic
- Cancer1▲ 3.7×8 topics
- Immune Response1▲ 8.3×3 topics
- Cell Proliferation1▲ 53×2 topics
- BRAF gene1▲ 238×1 topic
- Gene Expression1▲ 7.3×5 topics
- MAP Kinase1▲ 238×1 topic
- Tumor Microenvironment1▲ 12×3 topics
- Tumor Targeting1▲ 32×2 topics
- Neoadjuvant Therapy1▲ 18×2 topics
- Precision Medicine1▲ 13×5 topics
Which research topics does Immuneering (United States) publish most on?
By volume in 2022–2025: Melanoma and MAPK Pathways, Cancer Research and Treatments, Cancer Genomics and Diagnostics and Advanced Breast Cancer Therapies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Melanoma and MAPK Pathways Molecular Biology 1 works
- 2 Cancer Research and Treatments Biotechnology 1 works
- 3 Cancer Genomics and Diagnostics Cancer Research 0 works
- 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 5 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
- 6 Colorectal Cancer Treatments and Studies Oncology 0 works
- 7 Cancer Cells and Metastasis Oncology 0 works
- 8 Pancreatic and Hepatic Oncology Research Oncology 0 works
- 9 Genomics and Phylogenetic Studies Molecular Biology 0 works
- 10 Chromosomal and Genetic Variations Plant Science 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Immuneering (United States)'s research output changed?
Output in 2018–2022 was 83% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- Foundation Medicine (United States)
- GE Vernova (United States)
- Communicating Diet and Activity Research
- Thoth Open Metadata
- Cancer Imaging Centre
- Stanley Center for Psychiatric Research
- eLife Sciences Publications
- Real Colegio Complutense
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.